Copyright
©The Author(s) 2022.
World J Clin Cases. Nov 26, 2022; 10(33): 12156-12163
Published online Nov 26, 2022. doi: 10.12998/wjcc.v10.i33.12156
Published online Nov 26, 2022. doi: 10.12998/wjcc.v10.i33.12156
Table 3 Survival rates of the transarterial chemoembolization and radiofrequency ablation group and transarterial chemoembolization group
| Mo | TACE (%) | TACE-RFA (%) | χ2 | P value |
| 6 | 36.8 | 68.8 | 9.986 | 0.002 |
| 12 | 7.9 | 34.4 | 9.036 | 0.003 |
| 24 | 0 | 10.9 | 4.462 | 0.035 |
- Citation: Sun SS, Li WD, Chen JL. Transarterial chemoembolization combined with radiofrequency ablation in the treatment of large hepatocellular carcinoma with stage C. World J Clin Cases 2022; 10(33): 12156-12163
- URL: https://www.wjgnet.com/2307-8960/full/v10/i33/12156.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i33.12156